Incyte, US45337C1027

Incyte stock heads into the open after a 1.23 percent drop

Published on 09/25/2026 at 05:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, Incyte stock stood at USD 126.93 on the Nasdaq after falling 1.23 percent. The Nasdaq Composite was virtually flat on September 24, 2026, at 26,939.37.

Schwarzweiß-Dokumentarfoto einer Forscherin mit Laborampullen
Incyte Forscherin prüft Reagenzgläser in Schwarzweiß-Reportage, dokumentarisches Symbol für ISIN US45337C1027 Biotechnologie, Illustration mit AI erstellt.

Incyte stock closed at USD 126.93 on the Nasdaq on September 22, 2026, after falling 1.23 percent. The Nasdaq Composite ended at 26,939.37 on September 24, 2026, with a gain of less than 0.1 percent, providing a dated market comparison. Simply Wall St published a valuation analysis on September 24, 2026.

September 22, 2026 in numbers

Incyte Corporation (ISIN US45337C1027, Nasdaq: INCY) closed at USD 126.93 on September 22, 2026, down 1.23 percent from the prior Nasdaq close. The dated market result is below the USD 127.29 quote shown by Robinhood on September 25, 2026, but that later value is not used as a session close.

The September 24, 2026 Nasdaq Composite close of 26,939.37 was virtually unchanged, while the index gained 1.6 percent for the week. The available dated Incyte session figure therefore shows a weaker stock result than the broad technology-heavy index comparison.

September 25, 2026 outlook

The pre-market view centers on the valuation discussion published by Simply Wall St on September 24, 2026, which cited a last close of USD 124.44 and discussed fresh data involving Incyte programs. Market conditions also include higher Treasury yields and oil-price volatility, factors highlighted in the September 24 market wrap as the Nasdaq finished virtually flat.

Disclaimer...

en | US45337C1027 | INCYTE | boerse | 70180494 | bgmi